Tocilizumab long-term extension trial in patients with adult onset still
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 19 Feb 2018
At a glance
- Drugs Tocilizumab (Primary)
- Indications Adult-onset Still's disease
- Focus Adverse reactions; Therapeutic Use
- 17 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 27 Jul 2015 New trial record
- 24 Jul 2015 Status changed from not yet recruiting to recruiting, according to University Hospital Medical Information Network - Japan record.